by Eric Christianson | Nov 20, 2022 | Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
We’ve been doing some work lately to develop a chart of commonly used drugs with pharmacogenomic considerations. In anticipation of that table, I thought I’d share my top 5 medications that have pharmacogenomic considerations. If you are taking a board...
by Eric Christianson | Nov 16, 2022 | Cardiovascular Medication and Disease State Clinical Pearls
Post-MI there are a lot of medications most patients will be started on, and it can get confusing for both patients and providers. Today, we’re clearing up some of the confusion surrounding the choice behind which platelet aggregation inhibitors should be used. We’ll...
by Eric Christianson | Oct 26, 2022 | Gastrointestinal Medication and Disease State Clinical Pearls
Gastroparesis is a condition in which stomach motility is reduced due to nerve injury and/or muscle dysfunction. Due to this reduced motility, the stomach is unable to properly empty itself, leading to symptoms that may include nausea, vomiting, bloating, heartburn,...
by Eric Christianson | Oct 23, 2022 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Z-drugs, otherwise known as benzodiazepine receptor agonists, are used to help patients with insomnia that is associated with difficulty falling asleep (sleep latency), difficulty staying asleep (sleep maintenance), or not feeling rested after a night’s sleep (sleep...
by Eric Christianson | Oct 19, 2022 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Acute migraine affects up to 26% of women, and up to 9% of men in the US. It is characterized by a moderate to severe headache that lasts for 4-72 hours and may be unilateral, cause nausea/vomiting, pulsating pain, or photophobia. First-line treatment options include...
by Eric Christianson | Oct 16, 2022 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Benzodiazepines are prescribed to over 5% of the United States population and that number continues to grow. This class of medications is responsible for facilitating the binding of the inhibitory neurotransmitter GABA-A at various GABA receptors throughout the...
